THE REFERENCES FROM THE ARTICLE
"TREATMENT OPTIONS FOR GLIOBLASTOMA AND OTHER GLIOMAS" BY BEN
WILLIAMS
(Last Updated:
September 25, 2002. Source: http://www.virtualtrials.com/williams.cfm
)
Part 1 - Reference Numbers from 1 to 20 (Glioblastoma
Newsletter, 2 Oct. 2002, Vol. 1, No. 6)
Part 2 - Reference Numbers from 21 to 40 (Glioblastoma
Newsletter, 14 Oct. 2002, Vol. 1, No. 9)
Part 3 - Reference Numbers from 41 to 60 (Glioblastoma
Newsletter,
5 Oct. 2002, Vol. 1, No. 7)
Part 4 - Reference Numbers from 61 to 80 (Glioblastoma
Newsletter, 7 Oct. 2002, Vol. 1, No. 8)
Part 5 - Reference Numbers from 81 to 100 (Glioblastoma
Newsletter, 22 Oct. 2002, Vol. 1, No. 10)
Part 6 - Reference Numbers from 101 to 111
(This issue, that completes the references of the article)
The whole set of references is at the website
of Glioblastoma Newsletter, Section Overall Management.
|
|
|
101 |
Chakravarti A, Loeffler JS, Dyson NJ
Insulin-like growth factor receptor I mediates
resistance to anti-epidermal growth factor receptor therapy in primary human
glioblastoma cells through continued activation of phosphoinositide 3-kinase
signaling
Cancer Res 2002 Jan 1;62(1):200-7 (Cell Culture Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11782378&dopt=Abstract
|
|
102 |
Singh RP, Dhanalakshmi S, Tyagi AK, Chan DC, Agarwal C,
Agarwal R
Dietary feeding of silibinin inhibits advance human
prostate carcinoma growth in athymic nude mice and increases plasma insulin-like
growth factor-binding protein-3 levels
Cancer Res 2002 Jun 1;62(11):3063-9 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12036915&dopt=Abstract
|
|
103 |
Laske
DW, Youle RJ, Oldfield EH
Tumor regression
with regional distribution of the targeted toxin TF-CRM107 in patients with
malignant brain tumors
Nat
Med 1997 Dec;3(12):1362-8 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9396606&dopt=Abstract
|
|
104 |
Rand RW, Kreitman RJ, Patronas N,
Varricchio F, Pastan I, Puri RK
Intratumoral
administration of recombinant circularly permuted interleukin-4-Pseudomonas
exotoxin in patients with high-grade glioma
Clin Cancer Res 2000 Jun;6(6):2157-65 (Clinical
Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10873064&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=full&pmid=10873064
|
|
105 |
Patel
Sunil, Ke Spicer, Pamel
VanTassel, Stephe Haines, Leonni Gordon, Ar Frankel,
Jami Oliver
Phase I Results of
Intra-Tumoral Infusion of I-131
ch-TNT-1/B in the Treatment of Recurrent Malignant Gliomas
ASCO
Proceedings, 1999 Annual Meeting, Abstract No. 550 (Clinical Study)
Source: http://www.asco.org/asco/ascoMainConstructor/1,1003,_12-002324-00_29-00A-00_18-001999-00_19-0014803,00.asp
|
|
106 |
Klatzmann D, Valery CA, Bensimon G, Marro B, Boyer O, Mokhtari K,
Diquet B, Salzmann JL, Philippon J
A
phase I/II study of herpes simplex virus type 1 thymidine kinase
"suicide" gene therapy for recurrent glioblastoma. Study Group on Gene
Therapy for Glioblastoma
Hum
Gene Ther 1998 Nov 20;9(17):2595-604 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9853526&dopt=Abstract
|
|
107 |
Chang
SM, Kuhn JG, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME,
Pollack I, Schiff D, Gilbert M, Rankin C, Prados MD
Phase
II study of phenylacetate in patients with recurrent malignant glioma: a North
American Brain Tumor Consortium report
J Clin Oncol 1999 Mar;17(3):984-90 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10071293&dopt=Abstract
|
|
108 |
Engelhard
HH, Homer RJ, Duncan HA, Rozental J
Inhibitory
effects of phenylbutyrate on the proliferation, morphology, migration and
invasiveness of malignant glioma cells
J Neurooncol 1998 Apr;37(2):97-108 (Cell Culture Study,
Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9524087&dopt=Abstract
|
|
109 |
Matthew J.
Baker, Steven Brem, Stephanie Daniels, Beverly Sherman, Surasak Phuphanich
Complete Response of a Recurrent,
Multicentric Malignant Glioma in a Patient Treated with Phenylbutyrate
Journal
of Neuro-Oncology,
59
(3): 239-242, September 2002 (Case Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12241121&dopt=Abstract
|
|
110 |
Pili
R, Kruszewski MP, Hager BW, Lantz J, Carducci MA
Combination
of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and
angiogenesis
Cancer
Res 2001 Feb 15;61(4):1477-85 (Cell Culture Study,
Abstract | Full Text)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11245454&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://cancerres.aacrjournals.org/cgi/pmidlookup?view=full&pmid=11245454
|
|
111 |
Zheng
X, Chang RL, Cui XX, Kelly KA, Shih WJ, Lin Y, Strair R, Suh J, Han ZT,
Rabson A, Conney AH
Synergistic
effects of clinically achievable concentrations of
12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic
acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in
HL-60 cells
Oncol Res 2000;12(9-10):419-27 (Cell Culture Study,
Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11697820&dopt=Abstract
|
|
Volume 1, Number 11 - 24 October 2002